Selective toxic effects of tamoxifen on osteoclasts: Comparison with the effects of oestrogen

被引:33
作者
Arnett, TR
Lindsay, R
Kilb, JM
Moonga, BS
Spowage, M
Dempster, DW
机构
[1] HELEN HAYES HOSP,NEW YORK STATE DEPT HLTH,REG BONE CTR,W HAVERSTRAW,NY 10993
[2] COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032
[3] COLUMBIA UNIV,DEPT PATHOL,NEW YORK,NY 10032
[4] KNOLL PHARMACEUT,NOTTINGHAM NG2 3AA,ENGLAND
关键词
D O I
10.1677/joe.0.1490503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the actions of the trans- and cis-isomers of tamoxifen on the function of neonatal rat osteoclasts in vitro. Both compounds inhibited resorption pit formation by osteoclast-containing mixed bone cell cultures incubated for 24 h on cortical bone slices. Cell counts revealed that the inhibition was closely related to a cytotoxic effect, to which osteoclasts appeared particularly sensitive. Partial inhibition of resorption was seen in the presence of 2 mu M trans-tamoxifen, whereas complete abolition of resorption and osteoclast viability occurred with 10 mu M trans-tamoxifen; survival of mononuclear cells was unimpaired at either concentration. Cis-tamoxifen appeared to be slightly more toxic, with significant inhibitions osteoclast viability and thus resorption pit formation at a concentration of 2 mu M, and also of mononuclear cell numbers at 10 mu M. Time-lapse video observations indicated that osteoclast death occurred rapidly (within 2-3 h) following exposure to 10 mu M of either trans-tamoxifen or cis-tamoxifen. The morphological appearance of the dying cells was consistent with apoptosis. These results may help to explain the anti-resorptive action of tamoxifen seen in vivo in rats and humans. In contrast, oestradiol-17 beta consistently exerted no significant effects on resorption pit formation by rat osteoclasts over 24 h, even at grossly supraphysiological concentrations (up to 10 mu M).
引用
收藏
页码:503 / 508
页数:6
相关论文
共 28 条
[1]  
AMETT TR, 1986, J BONE MINER RES, V1, pS99
[2]   FAILURE OF ESTROGENS AND ANDROGENS TO INHIBIT BONE-RESORPTION IN TISSUE-CULTURE [J].
CAPUTO, CB ;
MEADOWS, D ;
RAISZ, LG .
ENDOCRINOLOGY, 1976, 98 (04) :1065-1068
[3]   REDUCTION OF THE MEMBRANE FLUIDITY OF HUMAN BREAST-CANCER CELLS BY TAMOXIFEN AND 17-BETA-ESTRADIOL [J].
CLARKE, R ;
VANDENBERG, HW ;
MURPHY, RF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (21) :1702-1705
[4]  
COLSTON KW, 1989, J BONE MINER RES, V4, P625
[5]   THE EFFECTS OF RALOXIFENE ON TIBIA HISTOMORPHOMETRY IN OVARIECTOMIZED RATS [J].
EVANS, G ;
BRYANT, HU ;
MAGEE, D ;
SATO, M ;
TURNER, RT .
ENDOCRINOLOGY, 1994, 134 (05) :2283-2288
[6]   MACROPHAGE-COLONY-STIMULATING FACTOR STIMULATES SURVIVAL AND CHEMOTACTIC BEHAVIOR IN ISOLATED OSTEOCLASTS [J].
FULLER, K ;
OWENS, JM ;
JAGGER, CJ ;
WILSON, A ;
MOSS, R ;
CHAMBERS, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1733-1744
[7]   EFFECT OF ESTROGEN ON ACIDIFICATION IN OSTEOCLASTS [J].
GAY, CV ;
KIEF, NL ;
BEKKER, PJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (03) :1251-1259
[8]  
HUGHES DE, 1995, BONE S, V16, pS93
[9]   INCREASED OSTEOCLAST DEVELOPMENT AFTER ESTROGEN LOSS - MEDIATION BY INTERLEUKIN-6 [J].
JILKA, RL ;
HANGOC, G ;
GIRASOLE, G ;
PASSERI, G ;
WILLIAMS, DC ;
ABRAMS, JS ;
BOYCE, B ;
BROXMEYER, H ;
MANOLAGAS, SC .
SCIENCE, 1992, 257 (5066) :88-91
[10]   EFFECT OF TAMOXIFEN ON LUMBAR SPINE BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN AFTER 5 YEARS [J].
LOVE, RR ;
BARDEN, HS ;
MAZESS, RB ;
EPSTEIN, S ;
CHAPPELL, RJ .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (22) :2585-2588